Confira os artigos sobre o tema da nossa Reunião de Agosto
Overall survival according to type of surgery in young (40 years)
Management of breast cancer in very young women
Improving Adjuvant Endocrine Treatment Tailoring in Premenopausal Women With Hormone Receptor–Positive Breast Cancer
Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women
Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival
Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT
Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor Positive, HER2 Negative Patients Likely to Benefit From Neoadjuvant Chemotherapy
How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery?
Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27
Does a positive axillary lymph node needle biopsy predict the need for an axillary lymph node dissection in clinically node-negative breast cancer patients in the ACOSOG Z0011 era?
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy